Sonu, an AI-enabled wearable device, is now approved for use in pediatric patients aged 12 years and older for the relief of moderate to severe nasal ...

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

In 2022, the Biden administration issued the existing directive to hospitals in an effort to preserve abortion access for extreme cases in which women were experiencing medical emergencies and needed ...

HealthDay News — A 1-unit increase in lead levels is associated with worse academic performance throughout school grades, according to a study published online May 28 in JAMA Network Open.

HealthDay News — A federal judge has ruled that transgender inmates in US prisons must continue getting medical care, including hormone therapy and gender-affirming accommodations.

The ASCENT-03 trial is a phase 3 study assessing the efficacy and safety of sacituzumab govitecan compared with physician’s choice of treatment in patients with previously untreated, locally advanced, ...

Individuals with recall related inquiries can contact Amneal Pharmaceuticals at (833) 582-0812 or via email at [email protected]. Adverse reactions should be reported to ...

Arakoda, an 8-aminoquinolone antimalarial, was approved in 2018 for the prophylaxis of malaria in patients aged 18 years and older.

The approval was supported by data from the randomized, double-blind, placebo-controlled, phase 3 ARANOTE trial.

The FDA is expected to decide on treatments for multiple myeloma, NSCLC, melanoma, phenylketonuria, and 2 rare kidney diseases.

Inverse correlation seen for arterial flow mediated dilation with smoking frequency and amount of THC ingested.

Findings seen in women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for HR-positive breast cancer.